Octreotide Is Ineffective in Treating Tumor-Induced Osteomalacia: Results of a Short-Term Therapy

Journal of Bone and Mineral Research - United States
doi 10.1002/jbmr.3162
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Tumor-Induced Osteomalacia

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2011English

Detection of the Primary Tumor Site in Tumor-Induced Osteomalacia by Indium-111 Octreotide Scintigraphy: A Case Report

Clinical Neurology
Neurology
2008English

Tumor-Induced Osteomalacia; A Case Report.

Orthopedics & Traumatology
1995English

Nonremission and Recurrent Tumor‐induced Osteomalacia: A Retrospective Study

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2019English

Postoperative Chylothorax: Is Octreotide a Valid Therapy?

Journal of Case Reports and Studies
2015English

Evaluation of Tumor-Induced Osteomalacia With 111In-Pentetreotide Scintigraphy

Journal of Nuclear Medicine Technology
Nuclear MedicineRadiologyUltrasound TechnologyRadiologicalImagingMedicine
2013English

A Case of Tumor-Induced Osteomalacia Associated With an Organizing Hematoma

AACE Clinical Case Reports
2018English

Successful Management of Tumor Induced Osteomalacia With Radiofrequency Ablation: A Case Series

JBMR Plus
2019English

Tamoxifen-Induced Severe Acute Pancreatitis After a Short-Term Therapy: A Case Report

Turk Onkoloji Dergisi
Oncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy